Finding a Trial
The purpose of a clinical trial is to identify the most effective, safest treatment for a disease. Clinical trials are key steps in the U.S. Food and Drug Administration’s drug approval process. Participants can access cutting-edge therapies while playing a vital role in helping researchers develop new treatments.
Use the FARE Clinical Trial Finder to simplify your search for research studies that fit your needs:
- Fill out the filter menu below. Use keywords for a narrow search, or leave keywords blank for a broader search.
- Click the Search Trials button. Matching trial summaries will appear at right. Select LEARN MORE to view details.
- For more information, email or phone the site coordinator at the trial site nearest to you.
- We strongly recommend that you consult with your healthcare provider about any trials that interest you and refer to our terms of service below.
FARE Clinical Trial Finder searches studies listed on clinicaltrials.gov, a service of the U.S. National Institutes of Health that provides information on publicly and privately supported human clinical studies in all 50 states plus Washington, D.C., and in more than 190 countries and U.S. territories.
All food allergy patients who can give informed consent themselves, or through a legal representative, are eligible to join the FARE Patient Registry. This U.S. focused research study invites patients to complete a series of surveys, sharing their de-identified (anonymous) food allergy experiences with the research community, helping to advance understanding of the disease. All data is stored and maintained in a secure, password-protected database, assuring the privacy, security and confidentiality of all personal information. Learn more and register today to help drive research forward.
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis
Prospective, pragmatic standard of care clinical trial comparing dietary therapies of standard dairy elimination diet alone (DED) to dairy elimination plus food additive elimination (FREE)
Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure
The main objective of this study is to compare pholcodine exposure in patients having presented with a perianaesthetic anaphylactic reaction to a NMBA (cases) to pholcodine exposure in matched anaesthetised patients with injection of NMBA, who did not present with an anaphylactic reaction (controls). The secondary objectives of the study are: - To compare anti-pholcodine IgE, anti-ammonium IV IgE and total IgE levels between the case and control groups. - To study the concordance between exposure to pholcodine in cases and controls, by means of a patient self-questionnaire on the one hand and, on the other hand, by...
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
This is a Phase 2, open-label, extension study to assess the safety and tolerability of AK002, given monthly for 8 doses.
An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
The purpose of this study is to test the safety and effectiveness of Losartan potassium in subjects with Eosinophilic Esophagitis (EoE), both those with a connective tissue disorder (CTD) and those without a CTD.
Antihistamines in Eosinophilic Esophagitis
Researchers are assessing the safety and effectiveness of antihistamines in the treatment of eosinophilic esophagitis.
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
This trial evaluates the efficacy and safety of HDM SLIT-tablet in treatment of HDM AR. The efficacy is evaluated using an environmental exposure chamber (EEC). Subjects will be randomised to receive treatment with HDM SLIT-tablet and placebo 1:1.
A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients
Primary Objective: To assess tolerability and safety of SAR439794 [peanut extract (PE) sublingual immunotherapy (SLIT) adjuvanted with Glucopyranosyl Lipid A (GLA)] after repeated sublingual (SL) daily administration in peanut allergic adult and adolescent patients. Secondary Objective: To assess pharmacodynamics of SAR439794 after repeated SL daily administration in peanut allergic adult and adolescent patients.
A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
The purpose of this study is to evaluate the safety and tolerability of ASP0892 after intradermal (ID) injection in adolescent participants with peanut allergy.
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
The purpose of this study is to determine whether baked milk oral immunotherapy is safe in the treatment of cow's milk allergy.
Basophil Activation Test to Diagnose Food Allergy
The BAT II Study is a cross-sectional diagnostic study in which children with suspected IgE-mediated allergy to foods (namely cow's milk, egg, sesame and cashew), as defined by a history of an immediate-type allergic reaction to a food or no history of food consumption or the presence of food-specific IgE as documented by skin prick test or serum specific IgE, will undergo a diagnostic work-up to confirm or refute the diagnosis of IgE-mediated food allergy. Participants will be prospectively recruited from specialised Paediatric Allergy clinics in London and will undergo skin prick testing (SPT), specific IgE testing to allergen extracts...